BOSTON--(BUSINESS WIRE)--
Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
management will present at the Cowen Healthcare Conference on Tuesday,
March 13, 2018 at 12:00 p.m. ET.
The audio portion of management's remarks will be available live through
Vertex's website, www.vrtx.com
in the "Investors" section under the "News and Events" page. A replay of
the conference webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific
innovation to create transformative medicines for people with serious
and life-threatening diseases. In addition to clinical development
programs in CF, Vertex has more than a dozen ongoing research programs
focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now
located in Boston's Innovation District. Today, the company has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. Vertex is consistently recognized as one
of the industry's top places to work, including being named to Science
magazine's Top Employers in the life sciences ranking for eight years in
a row. For additional information and the latest updates from the
company, please visit www.vrtx.com.
(VRTX-WEB)
View source version on businesswire.com: http://www.businesswire.com/news/home/20180312006107/en/
Vertex Pharmaceuticals Incorporated
Investors:
Michael
Partridge, 617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach
Barber, 617-341-6470
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media
